IP Library Granted Patent US 9,980,732
Granted Patent B2
US 9,980,732 · App. 15/088,583 · Granted May 29, 2018

Methods, systems, and devices for the delivery of endoluminal prostheses

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,980,732
App. No.
15/088,583
Granted
May 29, 2018
Kind
B2
Abstract

Described are devices, methods, and systems for achieving occlusion of vascular vessels. Further described are certain reduced or low profile procedures and devices for the percutaneous occlusion of the saphenous vein, such as in the treatment of a varicose vein condition caused by venous reflux.

Claims (28)

1. A medical product for closing a vascular vessel of a patient, comprising:

an endoluminal delivery device having an atraumatic distal end, wherein the endoluminal delivery device is advancable through a vascular vessel; and

an occlusion device releasably received on the endoluminal delivery device;

wherein the occlusion device has sufficient column strength for sheathless advancement through the vascular vessel;

wherein the occlusion device includes a volume of occlusive material advanceable through the vascular vessel on the endoluminal delivery device and sufficient to close the vascular vessel;

wherein the occlusive material comprises sponge form material; and

wherein the occlusion device has a column strength between about 200 kPA and about 12,000 kPA

wherein the occlusion device is at least about 10 cm in length;

wherein the occlusion device defines an aperture extending longitudinally therethrough for slidably receiving a wire guide; and

wherein the sponge form material expands to close the aperture after removal of the wire guide.

2. The medical product of claim 1 , wherein the endoluminal delivery device comprises one or more adaptations for releasably receiving the occlusion device.

3. The medical product of claim 1 , wherein the endoluminal delivery device comprises an aperture for receiving a wire guide.

4. The medical product of claim 1 , wherein the endoluminal delivery device is self-guiding.

5. The medical product of claim 4 , wherein the endoluminal delivery device is configured for vascular access through an introduction device.

6. The medical product of claim 5 , wherein the introduction device comprises a cannulated device.

7. The medical product of claim 1 , wherein the occlusion device comprises biocompatible material.

8. The medical product of claim 7 , wherein the biocompatible material comprises a remodelable material or a synthetic material.

9. The medical product of claim 8 , wherein the remodelable material comprises an extracellular matrix material or an absorbable material.

10. The medical product of claim 9 , wherein the extracellular matrix material comprises submucosa.

11. The medical product of claim 10 , wherein the submucosa comprises small intestine submucosa.

12. The medical product of claim 11 , wherein the small intestine submucosa comprises porcine small intestine submucosa.

13. The medical product of claim 1 , wherein the occlusion device is up to 60 cm in length.

14. The medical product of claim 1 , wherein the occlusion device is at least 25 cm in length.

15. The medical product of claim 1 , wherein the occlusion device is at least 35 cm in length.

16. The medical product of claim 1 , wherein the occlusion device is at least 50 cm in length.

17. The medical product of claim 1 , wherein the volume of occlusive material is expandable from a first configuration arranged for advancement through the vascular vessel to a second configuration arranged to close the vascular vessel.

18. The medical product of claim 1 , wherein the volume of occlusive material is compressed in the first configuration and effective to expand when wetted with water or other fluid.

19. The medical product of claim 1 , wherein the sponge form material comprises collagen.

Assignments (3)
SECURITY INTEREST Recorded Feb 28, 2024
From: COOK MEDICAL TECHNOLOGIES LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 066700/0277 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 19, 2016
From: PAUL, RAM H.; CASE, BRIAN C.; FLAGLE, JACOB A.
To: COOK INCORPORATED
Reel/Frame 038644/0586 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 19, 2016
From: COOK INCORPORATED
To: COOK MEDICAL TECHNOLOGIES LLC
Reel/Frame 038644/0739 →